Senior insider sale
CEO at EDITAS MEDICINE, INC. — senior position signals high conviction
$32.0K
12.59K shares
What this filing means
O'NEILL GILMORE NEIL plans to sell 12.59K shares of EDITAS MEDICINE, INC. valued at approximately $32.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/1/2025ACC: 0001650664-25-000158
DirectorOfficer· CEO
Since Jun 2022
12.59K
Shares to sell
$32.0K
Approx. market value
11.29K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
12/2/2025
11.29KTotal acquired11.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/2/2025 | Restricted Stock Unit Vesting Equity Compensation | 11.29K | — |
| Total | 11.29K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.59K
Market value
$14.5K
9/3/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
7K
Market value
$17.5K
12/3/2025
Total
Units
12.59K
Value
$32.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/3/2025 | 5.59K | $14.5K | — | Completed |
| Planned — Approximate Date | ||||
12/3/2025 | 7K | $17.5K | Nasdaq | Planned |
| Total | 12.59K | $32.0K | ||